HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chusilp Charnsangavej Selected Research
Chusilp Charnsangavej Research Topics
Disease
26
Neoplasms (Cancer)
07/2014 - 09/2002
9
Neoplasm Metastasis (Metastasis)
11/2015 - 10/2006
7
Adenocarcinoma
01/2012 - 02/2002
4
Pancreatic Neoplasms (Pancreatic Cancer)
12/2012 - 03/2006
3
Breast Neoplasms (Breast Cancer)
11/2015 - 11/2003
3
Carcinoma (Carcinomatosis)
08/2004 - 02/2002
2
Portal Hypertension
05/2010 - 10/2009
2
Colorectal Neoplasms (Colorectal Cancer)
05/2010 - 10/2009
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2010 - 08/2007
2
Hepatocellular Carcinoma (Hepatoma)
04/2008 - 08/2004
2
Disease Progression
03/2008 - 03/2006
2
Melanoma (Melanoma, Malignant)
04/2006 - 10/2004
2
Cholangiocarcinoma
08/2004 - 07/2002
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2013
1
Squamous Cell Carcinoma of Head and Neck
12/2011
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011
1
Thrombocytopenia (Thrombopenia)
05/2010
1
Glioma (Gliomas)
11/2009
1
Carcinoid Tumor (Carcinoid)
03/2008
1
Necrosis
07/2007
1
Klatskin Tumor
06/2007
1
Thrombosis (Thrombus)
10/2006
1
Inflammation (Inflammations)
10/2006
1
Lymphadenopathy
03/2006
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
03/2006
1
Hemorrhage
03/2006
1
Atrophy
11/2004
1
Kaposi Sarcoma (Kaposi's Sarcoma)
10/2004
1
Fibrosis (Cirrhosis)
08/2004
1
Hypersensitivity (Allergy)
09/2002
1
Hypertrophy
09/2002
Drug/Important Bio-Agent (IBA)
6
Bevacizumab (Avastin)
FDA Link
12/2012 - 03/2006
5
Contrast Media
IBA
08/2007 - 11/2003
3
Biomarkers (Surrogate Marker)
IBA
12/2011 - 09/2002
3
CY5.5 cyanine dye
IBA
11/2009 - 11/2003
2
Cytidine Triphosphate (CTP)
IBA
07/2014 - 07/2012
2
Imatinib Mesylate (Gleevec)
FDA Link
12/2011 - 03/2006
2
Tyrosine Kinase Inhibitors
IBA
12/2011 - 10/2005
2
Indicators and Reagents (Reagents)
IBA
09/2010 - 01/2010
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
05/2010 - 10/2009
2
Interferons
IBA
01/2010 - 03/2008
2
Peptides (Polypeptides)
IBA
11/2009 - 10/2004
2
paclitaxel poliglumex (XYOTAX)
IBA
07/2007 - 01/2004
2
Pentetic Acid (DTPA)
FDA Link
Generic
07/2007 - 04/2006
2
Capecitabine (Xeloda)
FDA Link
03/2006 - 08/2004
2
Cetuximab (Erbitux)
FDA Link
01/2004 - 11/2003
2
Proteins (Proteins, Gene)
FDA Link
01/2004 - 10/2003
2
Annexin A5
IBA
01/2004 - 10/2003
2
Irinotecan (Camptosar)
FDA Link
Generic
05/2002 - 02/2002
2
Cisplatin (Platino)
FDA Link
Generic
05/2002 - 02/2002
1
Docetaxel (Taxotere)
FDA Link
12/2011
1
Taxoids (Taxanes)
IBA
12/2011
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
12/2011
1
Fluorouracil (Carac)
FDA Link
Generic
05/2010
1
Cytostatic Agents
IBA
12/2009
1
Gemcitabine
FDA Link
07/2008
1
Octreotide (Sandostatin)
FDA Link
Generic
03/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2008
1
Thalidomide (Thalomid)
FDA Link
08/2007
1
Gadolinium
IBA
07/2007
1
Acids
IBA
07/2007
1
Vitronectin
IBA
04/2006
1
Semaxinib (SU5416)
IBA
10/2005
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
10/2005
1
Polyvinyl Alcohol
IBA
10/2005
1
Phenobarbital (Luminal)
FDA Link
10/2005
1
Axitinib (AG 013736)
IBA
08/2005
1
Angiogenesis Inhibitors
IBA
08/2005
1
Polymers
IBA
11/2004
1
Fluconazole (Zonal)
FDA Link
Generic
11/2004
1
Coloring Agents (Dyes)
IBA
10/2004
1
Integrin alphaVbeta3
IBA
10/2004
1
IRDye800
IBA
10/2004
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
01/2004
1
taxane
IBA
01/2004
1
ErbB Receptors (EGF Receptor)
IBA
11/2003
1
Monoclonal Antibodies
IBA
11/2003
1
Epidermal Growth Factor (EGF)
IBA
11/2003
1
Endostatins
IBA
09/2002
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
09/2002
1
Antibodies
IBA
09/2002
1
Paclitaxel (Taxol)
FDA Link
Generic
05/2002
Therapy/Procedure
15
Therapeutics
11/2015 - 05/2002
11
Drug Therapy (Chemotherapy)
11/2015 - 05/2002
5
Radiotherapy
07/2008 - 05/2002
4
Aftercare (After-Treatment)
11/2015 - 01/2004
3
Pancreaticoduodenectomy
01/2012 - 05/2002
2
Neoadjuvant Therapy
12/2012 - 01/2012
2
Intravenous Injections
11/2009 - 11/2004
1
Lymph Node Excision (Lymph Node Dissection)
07/2013
1
Pancreatectomy
12/2012
1
Cholecystectomy
07/2010
1
Nephrectomy
07/2010
1
Laparotomy
06/2007
1
Contraindications
09/2002
1
Length of Stay
09/2002